文献速递系统性红斑狼疮

利用自然语言处理框架通过人工智能识别系统性红斑狼疮的临床表型与疾病轨迹

Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究基于电子健康记录(EHR),开发结合人工智能与人类智能的自然语言处理(NLP)流程,用于识别系统性红斑狼疮(SLE)患者的临床表型与疾病轨迹。在262例符合条件的患者中,首次接触时43%为高复杂度表型,且该组随时间经历更多复发(5次 vs 3次和3次,P<0.001)。该框架为研究SLE异质性与进展提供了可行工具。

要点

  • 首次接触时高复杂度表型占43%,其复发次数显著多于中、低复杂度组(5 vs 3和3,P<0.001)。
  • 低、中复杂度表型患者随访期间新临床领域增加及传统免疫抑制剂、生物制剂和糖皮质激素使用增幅更高。
  • 基于EHR的NLP流程可纵向刻画SLE表型,有望用于临床研究与患者管理。

核心结论

  • 基于真实世界数据的NLP框架可实现SLE患者纵向表型刻画,揭示疾病异质性与进展。

研究设计与样本

  • 纳入SLE患者EHR数据,设计结合AI与人类智能的标准化阶梯式框架,基于本体定义提取临床领域、复发及疾病复杂度表型。
  • 从1000例提取患者中,262例符合纳入标准(≥1次住院、≥1次门诊就诊且随访≥1.5年)。

主要发现

  • 262例患者中88%为女性,中位年龄43岁,中位随访6年。
  • 首次接触时最常见临床领域为血液系统(64%)、关节(47%)、皮肤(59%)和肾脏(58%)。
  • 首次接触时高复杂度表型占43%,中复杂度35%,低复杂度22%。
  • 高复杂度表型组随时间经历更多复发(5 vs 3和3,P<0.001)。
  • 低、中复杂度表型患者随访期间新临床领域增加及传统免疫抑制剂、生物制剂和糖皮质激素使用增幅更高。

临床怎么用

  • 该NLP框架可作为可行工具用于研究SLE异质性与进展,为临床研究和患者管理提供洞察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Electronic health records (EHRs) contain a wealth of unstructured patient data that can be leveraged using artificial intelligence (AI). This study aimed to develop a natural language processing (NLP) pipeline to identify clinical phenotypes and disease trajectories in patients with systemic lupus erythematosus (SLE) from EHRs. METHODS: EHR data from SLE patients were included. A standardized stepwise framework combining AI and human intelligence (HI) was designed. Ontology-based definitions were developed for clinical domains, flares and disease complexity phenotypes (low, medium, high) at the first contact, and corresponding data were extracted using an NLP-based pipeline. RESULTS: Out of 1,000 extraxcted patients, inclusion criteria were met by 262 who had ≥1 hospitalization, ≥1outpatient visit, and a follow-up ≥1.5 years. Among these, 88% were female, median age was 43 years, median follow-up 6 years. At first contact, the most frequently involved clinical domains were hematological (64%), articular (47%), cutaneous (59%) and renal (58%). At first contact, 43% of patients presented with a high-complexity phenotype, 35% medium, 22% low complexity: the first group experienced more flares over time (5 vs 3 and 3, P < 0.001). Patients with a low and medium-complexity phenotype showed a higher increase in new clinical domains and in the use of conventional immunosuppressants, biologics and glucocorticoids during follow-up. CONCLUSION: This novel framework, based on real-world data, enables longitudinal phenotype characterization of SLE patients. It demonstrates promise as a feasible tool to study the heterogeneity of SLE and its progression over time, offering insights into potential applications in clinical research and patient management.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Bosello SL, Ortolan A, Lanzo L, et al. Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework. Rheumatology (Oxford). 2026. PMID: 41701167. doi:10.1093/rheumatology/keag035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。